Ingelfinger imperative: when speed of release risks quality of research-Reference-Cited by-同舟云学术

Ingelfinger imperative: when speed of release risks quality of research

Published:2020-12 Issue:12 Volume:50 Page:1595-1596
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Fanning Jonathon P.¹²³^ORCID,Cohen Jeremy¹²⁴,Venkatesh Balasubramanian¹²⁵

Affiliation:

1. Faculty of Medicine The University of Queensland Brisbane Queensland Australia

2. Intensive Care Unit The Wesley Hospital Brisbane Queensland Australia

3. Critical Care Research Group The Prince Charles Hospital Brisbane Queensland Australia

4. Department of Intensive Care Medicine The Royal Brisbane and Women's Hospital Brisbane Queensland Australia

5. The George Institute for Global Health University of New South Wales Sydney New South Wales Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15047

Reference7 articles.

1. Oxford University News Release. Low‐cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID‐19. 2020 [cited 2020 Jun 16]. Available from URL:https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf

2. WHO Newsroom. WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID‐19 patients. 2020 [cited 2020 Jun 16]. Available from URL:https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients

3. The Ingelfinger Rule Revisited

4. The rush to publication – an editorial and scientific mistake;Bauchner H;JAMA,2017

5. Editorial Evaluation and Peer Review During a Pandemic